- Concentration: 0.1% Dexamethasone (1mg/ml)
- Volume: 5ml or 10ml per bottle
- Packaging: Sterile plastic dropper bottle, 1 bottle/box
- Shelf Life: 24 months (unopened)
Package:
Product Description
0.1% Dexamethasone Sodium Phosphate Eye Drops 10mL: What the Published Guidance Says
Fifteen ophthalmic products spanning anti-infective, anti-allergic, anti-inflammatory, antiviral and ocular-surface categories — including the two anti-infectives the WHO Model List names for conjunctivitis and infectious keratitis.
0.1% Dexamethasone Sodium Phosphate Eye Drops 10mL is specified against its own monograph, pack size and market registration, so the guidance below is worth reading together with the Ophthalmic range overview.
- Trachoma and endophthalmitis have separate recommendations For trachoma the treatment of choice is a single oral dose of azithromycin, with topical azithromycin or tetracycline also indicated. For bacterial endophthalmitis, the listings for ceftazidime, ceftriaxone and vancomycin were extended to cover it as a first-choice option, with the Committee noting that intravitreal administration requires specialist training and adequate infrastructure. WHO eEML — Ofloxacin (ophthalmological)
- Evidence for conjunctivitis does not favour one antibiotic over another The Committee noted that topical antibiotics are indicated for moderate to severe infection and can be considered in mild cases, but that available evidence does not make it possible to identify specific, preferred antibiotics for conjunctivitis. It therefore endorsed the existing gentamicin and tetracycline listings rather than picking a winner. WHO eEML — Ofloxacin (ophthalmological)
- Ofloxacin 0.3% — for keratitis, and extended to conjunctivitis Ofloxacin eye drops 0.3% are listed for infectious keratitis, and in 2021 the Expert Committee recommended expanding the indication to include conjunctivitis. Topical fluoroquinolones are the class the Committee endorsed for infectious keratitis. WHO eEML — Ofloxacin (ophthalmological)
These points are quoted because they shape how 0.1% Dexamethasone Sodium Phosphate Eye Drops 10mL is specified, labelled and purchased — including strength selection, pack size and the artwork wording. Confirm each one against the approved product information in your market before finalising a purchase order.
0.1% Dexamethasone Sodium Phosphate Eye Drops 10mL — Supply Parameters
| Product Name | 0.1% Dexamethasone Sodium Phosphate Eye Drops 10mL (Dexamethasone Ophthalmic Solution) |
| Specification | 10mL sterile eye drops containing 0.1% (1 mg/mL) Dexamethasone (as Dexamethasone Sodium Phosphate) |
| Dosage Form | Sterile Ophthalmic Solution (Eye Drops — for topical ocular administration) |
| Active Ingredient | Dexamethasone Sodium Phosphate (Corticosteroid — Anti-inflammatory Agent) |
| Pharmacological Class | Anti-inflammatory Ophthalmic Agent (Corticosteroid) |
| Route of Administration | Topical ocular (instilled into the conjunctival sac). Typically 1-2 drops in the affected eye(s) every 4-6 hours initially, then reduced as directed. |
| Storage | Store at room temperature (15°C-25°C), protected from light. Keep container tightly closed. Do not freeze. Discard within 4 weeks of first opening. |
| Therapeutic group | Ophthalmic — Ophthalmic |
| Manufacturer | Sinophare Bio-technology Co., Ltd. (GMP, China) |
| Documentation supplied | COA, HPLC/GC data, stability data, dossier package |
The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: 5% Taurine Eye Drops 10mL, 1% Acyclovir Eye Drops 10mL, 0.5% Chloramphenicol Eye Drops 10mL, 0.3% Gentamicin Eye Drops 10mL, 0.5% Hypromellose Eye Drops 10mL, 0.5% Kanamycin Eye Drops 10mL, 2.5% Lincomycin Hydrochloride Eye Drops 10mL, 0.5% Moxifloxacin Hydrochloride Eye Drops 10mL.
Quality Control, Pharmacopoeial Standards & Documentation
Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.
0.1% Dexamethasone Sodium Phosphate Eye Drops 10mL is released against the pharmacopoeial monograph named on your order (USP, EP, BP or CP). Where no monograph exists for the exact presentation, the specification is agreed with you in writing before manufacture and is attached to the certificate of analysis.
Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.
A typical release panel for this presentation covers:
- Testing for description and identification
- Testing for assay of the active substance
- Testing for related substances and impurities
- Testing for dissolution or release profile (solid oral forms)
- Testing for uniformity of dosage units
- Testing for water content and pH where applicable
COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.
Packaging, Labelling & Export
- Pack size: Sterile multi-dose dropper bottle (10mL) with tamper-evident seal. Non-standard pack sizes can be quoted against your artwork.
- Storage: Store at room temperature (15°C-25°C), protected from light. Keep container tightly closed. Do not freeze. Discard within 4 weeks of first opening..
- Shelf life: 24 months unopened; discard within 4 weeks of first opening. Stability data for the marketed pack is included in the dossier.
- Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
- Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.
Registration, Dossier & Tender Support
Sinophare Bio-technology Co., Ltd. holds DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. That registration identifies the legal manufacturer on the certificate of analysis, the GMP certificate and the documents filed with your national medicines authority.
- CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
- Site Master File and GMP certificate for the manufacturing workshops.
- Method validation, stability protocol and the shelf-life justification for the marketed pack.
- Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
- Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
This page describes 0.1% Dexamethasone Sodium Phosphate Eye Drops 10mL as a product of the ophthalmic preparations used in WHO and MSF eye-care protocols family. A WHO or national listing is a supply-context fact, not an approval in your market; marketing authorisation remains specific to each country.
Frequently Asked Questions
What pack size is available for 0.1% Dexamethasone Sodium Phosphate Eye Drops 10mL?
The reference pack is Sterile multi-dose dropper bottle (10mL) with tamper-evident seal. Non-standard blister, bottle and carton configurations are quoted against your artwork, matched to the stability data already held for the presentation.
What documentation comes with a shipment of 0.1% Dexamethasone Sodium Phosphate Eye Drops 10mL?
Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 24 months unopened; discard within 4 weeks of first opening.
Does the batch documentation for 0.1% Dexamethasone Sodium Phosphate Eye Drops 10mL support a registration filing?
Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 24 months unopened; discard within 4 weeks of first opening. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.
Which ophthalmic anti-infectives are on the WHO Model List?
Gentamicin eye drops 0.3% (for infectious blepharitis) and ofloxacin eye drops 0.3% (infectious keratitis, with the indication extended to conjunctivitis in 2021). Amikacin, kanamycin, netilmicin and tobramycin are specified as therapeutic alternatives to gentamicin.
Do you supply preservative-free eye drops?
We can supply both preserved and preservative-free presentations depending on the product and your market requirement. Specify the preservative system on your enquiry.
Related Ophthalmic Products
- 5% Taurine Eye Drops 10mL — 10mL
- 1% Acyclovir Eye Drops 10mL — 10mL
- 0.5% Chloramphenicol Eye Drops 10mL — 10mL
- 0.3% Gentamicin Eye Drops 10mL — 10mL
- 0.5% Hypromellose Eye Drops 10mL — 10mL
- 0.5% Kanamycin Eye Drops 10mL — 10mL
Browse the full Ophthalmic range; all Ophthalmic; the complete product catalogue.
Request a Quotation for 0.1% Dexamethasone Sodium Phosphate Eye Drops 10mL
Send the specification, pack size, quantity and destination market for 0.1% Dexamethasone Sodium Phosphate Eye Drops 10mL 10mL and we will confirm availability, lead time and documentation. Tender quantities and registration samples are handled on the same quotation.
Sources & Regulatory Notes
Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.
